PMID: 11918693Mar 29, 2002Paper

Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies

Immunology
Gregory D HusseyStanley R Ress

Abstract

This study evaluated whether different bacillus Calmette-Guérin (BCG) strains, routes of administration, vaccination age and percutaneous tools influenced immune responses to BCG vaccination in infants. Proliferative responses, cytokine production and cell-mediated cytotoxicity obtained in post-vaccinated children were compared to baseline cord bloods and unvaccinated 10-week-old infants. BCG vaccination generally induced strong lymphoproliferative and T helper type 1 (Th1)-type cytokine responses. There was a trend for greater responsiveness following the intradermal route of vaccination, with Japanese-172 strain and with delaying vaccination until 10 weeks. Cord mononuclear cells differentially stimulated the Th2-type cytokines interleukin-5 (IL-5) and IL-10 selectively in response to BCG, as compared to H37Rv or purified protein derivative stimulation. We document for the first time the generation of mycobacterium-specific cytotoxic T lymphocytes in neonates, following BCG vaccination. Cytotoxic activity correlated with the ratio of interferon-gamma to IL-5, aside from a single instance where use of the Biovac tool resulted in a striking dissociation selectively against H37Rv targets. These data have implications for correla...Continue Reading

References

Jun 1, 1992·Current Opinion in Immunology·R de Waal MalefytJ E de Vries
Oct 12, 1995·Journal of Immunological Methods·N Petrovsky, L C Harrison
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Mar 15, 1994·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada
Mar 2, 1994·JAMA : the Journal of the American Medical Association·G A ColditzF Mosteller
Mar 22, 1996·Science·E Pennisi
Feb 1, 1997·Infection and Immunity·E B LindbladP Andersen
Sep 18, 1997·Immunology Today·P C Beverley
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·A LalvaniA V Hill
Mar 28, 1998·American Journal of Respiratory and Critical Care Medicine·N W Schluger, W N Rom
Jul 4, 1998·The Journal of Infectious Diseases·P W LowryD R Jacobs
Sep 2, 1998·Current Opinion in Immunology·S Stenger, R L Modlin
Feb 9, 1999·Novartis Foundation Symposium·R J Bellamy, A V Hill
Feb 9, 1999·Novartis Foundation Symposium·P E Fine
Mar 19, 1999·Emerging Infectious Diseases·S T QureshiD Malo
May 18, 1999·Archives of Disease in Childhood·M J Bannon
May 25, 1999·Infection and Immunity·P J Murray, R A Young
Jun 22, 1999·Lancet·J F AdamsA D Beyers
Jul 27, 1999·Nature·D B LowrieC L Silva
Sep 10, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·F GerosaG Trinchieri
Oct 26, 1999·Archives of Disease in Childhood·W Hoskyns
May 19, 2000·Cytokine & Growth Factor Reviews·S B CohenA Dickinson
Jun 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·N V SerbinaJ L Flynn
Jun 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J J EllnerC C Whalen
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D FörtschS Stenger
Sep 6, 2000·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·J TurnerH M Dockrell
Oct 25, 2000·International Journal of Medical Microbiology : IJMM·R BroschS T Cole

❮ Previous
Next ❯

Citations

Feb 9, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Neelja SinghalBeenu Joshi
Jun 5, 2003·International Journal for Parasitology·David N McMurray
Jul 2, 2004·Nature Reviews. Immunology·Becky AdkinsStuart Marshall-Clarke
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Samuel GrossAlex Leventhal
Jul 19, 2006·AIDS·Elizabeth J McFarlandJohn S Lambert
May 1, 2010·The Pediatric Infectious Disease Journal·Frank ShannUNKNOWN Working Group on Nonspecific Effects of Vaccines
May 2, 2007·Current Opinion in Infectious Diseases·Ajit Lalvani, Kerry A Millington
Oct 27, 2004·Infection and Immunity·Beate KampmannMichael Levin
Apr 2, 2013·American Journal of Respiratory and Critical Care Medicine·Nicole RitzNigel Curtis
Jun 19, 2010·American Journal of Respiratory and Critical Care Medicine·Benjamin M N KaginaUNKNOWN other members of the South African Tuberculosis Vaccine Initiative
Nov 11, 2011·American Journal of Respiratory and Critical Care Medicine·Nicole RitzNigel Curtis
Jun 5, 2004·Annals of Clinical Microbiology and Antimicrobials·Mauricio Castañón-Arreola, Yolanda López-Vidal
Jun 9, 2007·Journal of Immune Based Therapies and Vaccines·B AnuradhaValluri Vijaya Lakshmi
Jan 15, 2011·Clinical & Developmental Immunology·Patricia L SempleStanley Ress
Sep 26, 2012·Expert Review of Vaccines·Rogier BodewesGuus F Rimmelzwaan
Jan 1, 2014·The American Journal of the Medical Sciences·Mathan PeriasamyPerumal Venkatesan
Dec 12, 2012·Tuberculosis and Respiratory Diseases·Hyejon LeeHee Jin Kim
Jul 31, 2007·Vaccine·A C HesselingL Kuhn
Jun 19, 2007·Paediatric Respiratory Reviews·Gregory HusseyWillem Hanekom
Oct 24, 2006·Trends in Microbiology·Rosangela Salerno-Gonçalves, Marcelo B Sztein
Jun 17, 2005·Clinical and Experimental Immunology·A Marchant, M Goldman
Mar 24, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S L PrescottP Richmond
Jul 19, 2003·Clinical and Experimental Immunology·X LaiZ W Chen
Dec 14, 2005·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Y TaştanE Kiray
Nov 15, 2005·European Journal of Immunology·Hong-Ren YuKuender D Yang
Jul 12, 2008·FEMS Microbiology Reviews·Nicole RitzNigel Curtis
Aug 25, 2016·Microbial Pathogenesis·D Rosales-MartinezF Esquivel-Guadarrama

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.